Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug. [electronic resource]
Producer: 20140721Description: 6193-204 p. digitalISSN:- 1557-3265
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- biosynthesis
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Ascitic Fluid -- cytology
- Biological Transport
- Dendrimers -- pharmacology
- Female
- Gene Expression
- Gonadotropin-Releasing Hormone -- analogs & derivatives
- Humans
- Hyaluronan Receptors -- biosynthesis
- Mice
- Mice, Nude
- Nanomedicine
- Nanoparticles -- chemistry
- Neoplasm Invasiveness
- Neoplasm Transplantation
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Pilot Projects
- Polypropylenes
- RNA Interference
- RNA, Small Interfering -- administration & dosage
- Receptors, LHRH -- biosynthesis
- Transplantation, Heterologous
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.